ESSA Pharma Inc.

04/28/2021 | Press release | Distributed by Public on 04/28/2021 05:04

ESSA Pharma Announces Clinical Collaboration Agreement with Bayer to Evaluate the Combination of EPI-7386 and Darolutamide in Patients with Metastatic Castration-Resistant[...]